Page last updated: 2024-10-20

pyrazole and Cancer of Prostate

pyrazole has been researched along with Cancer of Prostate in 4 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Mohareb, RM1
Milad, YR1
El-Ansary, RA1
Bahashwan, SA1
Fayed, AA1
Ramadan, MA1
Amr, Ael-G1
Al-Harbi, NO1
Silva, F1
Marques, F1
Santos, IC1
Paulo, A1
Rodrigues, AS1
Rueff, J1
Santos, I1
Yamamoto, S1
Tomita, N1
Suzuki, Y1
Suzaki, T1
Kaku, T1
Hara, T1
Yamaoka, M1
Kanzaki, N1
Hasuoka, A1
Baba, A1
Ito, M1

Other Studies

4 other studies available for pyrazole and Cancer of Prostate

ArticleYear
New Approaches for the Synthesis of Fused Thiophene, Pyrazole, Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions.
    Anti-cancer agents in medicinal chemistry, 2021, Volume: 21, Issue:13

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug

2021
Androgen receptor antagonists and anti-prostate cancer activities of some newly synthesized substituted fused pyrazolo-, triazolo- and thiazolo-pyrimidine derivatives.
    International journal of molecular sciences, 2014, Nov-24, Volume: 15, Issue:11

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; CHO Cell

2014
Synthesis, characterization and cytotoxic activity of gallium(III) complexes anchored by tridentate pyrazole-based ligands.
    Journal of inorganic biochemistry, 2010, Volume: 104, Issue:5

    Topics: Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gall

2010
Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists.
    Bioorganic & medicinal chemistry, 2012, Apr-01, Volume: 20, Issue:7

    Topics: Administration, Oral; Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Cell Proliferation;

2012